CN Stock MarketDetailed Quotes

600196 Shanghai Fosun Pharmaceutical

Watchlist

25.90
-0.13-0.50%

Market Closed Dec 20 15:00 CST

69.19BMarket Cap32.74P/E (TTM)

Shanghai Fosun Pharmaceutical Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Shanghai Fosun Pharmaceutical FY2024 9-Month Earnings Date

Currency：CNYOct 29, 2024

	Estimate (YoY)	Actual (YoY)	Vs Estimate (% Chg)
Revenue	--	30.91B	--
		+0.69%
EPS	--	0.75	--
		-11.76%

Analyst Rating

Strong Buy

Dec 21, 2024

Shanghai Fosun Pharmaceutical Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: CNY

Actual

Estimate

Date	Period	Revenue/Estimate	Earnings Call
--	2025/Q1	-- / 10.266B	--
--	2024/Q4	-- / 10.839B	--
--	2024/Q3	10.449B / 10.338B	--
--	2024/Q2	10.226B / 10.561B	--
--	2024/Q1	10.157B / 10.691B	--

DatePeriodRevenue/EstimateEarnings Call

--2025/Q1-- / 10.266B--

--2024/Q4-- / 10.839B--

--2024/Q310.449B / 10.338B--

--2024/Q210.226B / 10.561B--

--2024/Q110.157B / 10.691B--

Unlock Free Earnings Estimates

Open Account

Shanghai Fosun Pharmaceutical Earnings Reports

Fosun Pharmaceuticals 2024 Third Quarter Report

Oct 29 12:00 ET

Fosun Pharmaceutical 2024 Semi-Annual Report

Aug 27 12:00 ET

Summary of Fosun Pharmaceutical\'s 2024 Semi-Annual Report

Aug 27 12:00 ET

Fosun Pharmaceuticals 2024 First Quarter Report

Apr 29 12:00 ET

Top CN Stock Gainers

Symbol Price % Chg

Zhejiang Lanyu Digital Technology

Hangzhou Raycloud Technology Co.,Ltd

688365

13.90 +20.03%

See the daily top gainer.

Analysis

Analyst Rating

Updated: Dec 21, 2024

Strong Buy

Strong Buy
70.00%
Buy
30.00%
Hold
0.00%
Underperform
0.00%
Sell
0.00%

Price Target

No Data

Investment Theme

Robot Concept

Intraday+0.86%

Assisted Reproduction

Intraday+0.68%

Virus Prevention

Intraday+0.60%